Physician profile
Polly Lin
NPI 1467175349
$14,308.62
in general payments reported to CMS, 2019-2025
65 companies · $4,820 in 2025
The $4,820 reported for 2025 was more than what 99% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $461 · 2023: $4,743 · 2024: $4,285 · 2025: $4,820.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $13K · Education: $1,048.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $12,799.97 |
| Education | $1,048.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,577.29 | 2022-2025 | Enhertu, Tagrisso, Calquence |
| Incyte Corporation | $1,102.51 | 2022-2025 | Jakafi, Monjuvi, Pemazyre |
| Novartis Pharmaceuticals Corporation | $884.17 | 2023-2025 | |
| Merck Sharp & Dohme LLC | $852.68 | 2022-2025 | Keytruda, Lynparza, Welireg |
| Pfizer INC. | $600.39 | 2022-2025 | |
| Celgene Corporation | $582.19 | 2023-2025 | Reblozyl, Opdualag |
| E.R. Squibb & Sons, L.L.C. | $552.34 | 2023-2025 | Opdivo, Opdualag |
| Seagen INC. | $492.85 | 2022-2025 | Adcetris, Padcev, Tukysa |
| Takeda Pharmaceuticals U.S.A., INC. | $416.20 | 2023-2025 | Iclusig, Fruzaqla, Alunbrig |
| Lilly USA, LLC | $388.32 | 2022-2025 | Verzenio, Jaypirca, Retevmo |
| Eisai INC. | $386.08 | 2023-2025 | |
| Abbvie INC. | $368.84 | 2023-2025 | |
| Exelixis INC. | $330.40 | 2023-2025 | Cabometyx |
| Karyopharm Therapeutics INC. | $299.79 | 2022-2025 | Xpovio |
| Daiichi Sankyo INC. | $299.35 | 2022-2025 | Enhertu |
Show all 65 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ipsen Biopharmaceuticals, INC | $279.01 | 2022-2025 | Onivyde, Tazverik, Somatuline Depot |
| Janssen Biotech, INC. | $273.51 | 2024-2025 | Carvykti, Talvey, Tecvayli |
| Genzyme Corporation | $266.41 | 2023-2025 | |
| Emd Serono, INC. | $257.91 | 2023-2025 | Bavencio |
| Astellas Pharma US INC | $241.98 | 2023-2025 | Xtandi, Padcev, Xospata |
| Stemline Therapeutics INC. | $240.46 | 2023-2025 | Orserdu, Elzonris |
| Pharmaessentia USA Corporation | $234.03 | 2023-2025 | Besremi |
| Genmab U.S., INC. | $219.02 | 2023-2025 | Epkinly |
| Regeneron Healthcare Solutions, INC. | $209.60 | 2023-2025 | Libtayo, Lynozyfic |
| Boehringer Ingelheim Pharmaceuticals, INC. | $203.84 | 2023-2025 | Gilotrif |
| Glaxosmithkline, LLC. | $198.85 | 2024-2025 | Zejula, Jemperli, Ojjaara |
| Puma Biotechnology, INC. | $194.15 | 2023-2024 | Nerlynx |
| Blueprint Medicines Corporation | $181.46 | 2023-2025 | Ayvakit |
| Gilead Sciences, INC. | $150.29 | 2023-2025 | Trodelvy |
| Janssen Scientific Affairs, LLC | $144.81 | 2023 | Erleada |
| Genentech USA, INC. | $137.13 | 2023-2025 | Venclexta, Polivy, Phesgo |
| Bayer Healthcare Pharmaceuticals INC. | $129.68 | 2023-2025 | |
| Taiho Oncology, INC. | $120.50 | 2022-2024 | |
| Alexion Pharmaceuticals, INC. | $114.66 | 2022-2024 | Ultomiris |
| Agios Pharmaceuticals, INC. | $111.65 | 2023-2025 | Pyrukynd |
| Array Biopharma INC | $107.14 | 2024-2025 | Braftovi, Mektovi, Lorbrena |
| Sun Pharmaceutical Industries INC. | $106.84 | 2024-2025 | |
| Sobi, INC | $88.63 | 2023-2025 | |
| Amgen INC. | $73.41 | 2023 | Nplate, Xgeva, Vectibix |
| Deciphera Pharmaceuticals INC. | $71.12 | 2025 | Romvimza, Qinlock |
| Tersera Therapeutics LLC | $67.60 | 2023 | Zoladex |
| Rigel Pharmaceuticals, INC. | $67.46 | 2023-2025 | Tavalisse, Rezlidhia, Tavalisse |
| Immunogen, INC. | $56.39 | 2023-2024 | Elahere, Elahere |
| Caris Mpi, INC. | $53.99 | 2025 | Mi Cancer Seek |
| Beigene USA, INC. | $48.33 | 2024-2025 | Brukinsa |
| Novocure INC. | $42.52 | 2025 | Optune Lua (Novottf-200t) |
| Progenics Pharmaceuticals, INC. | $39.22 | 2025 | |
| Mirati Therapeutics, INC. | $35.22 | 2023-2024 | Krazati |
| Shorla Oncology INC. | $34.84 | 2025 | |
| Foundation Medicine, INC. | $34.16 | 2023 | |
| Adc Therapeutics America, INC. | $33.75 | 2025 | |
| Iovance Biotherapeutics, INC. | $32.83 | 2025 | Amtagvi |
| Immunocore Limited | $31.91 | 2024 | Kimmtrak |
| Cti Biopharma Corp. | $29.43 | 2023 | Vonjo |
| Apellis Pharmaceuticals, INC. | $23.45 | 2023 | Empaveli |
| Geron Corporation | $22.57 | 2025 | Rytelo |
| Jazz Pharmaceuticals INC. | $21.47 | 2024 | |
| G1 Therapeutics, INC. | $21.00 | 2023 | Cosela |
| Spectrum Pharmaceuticals INC. | $20.61 | 2023 | Rolvedon |
| Legend Biotech USA INC. | $19.45 | 2025 | Carvykti |
| Pharmacosmos Therapeutics INC. | $17.79 | 2024 | Cosela |
| Tolmar Pharmaceuticals, INC. | $17.71 | 2022 | |
| Recordati_rare_diseases_inc. | $16.88 | 2024 | Sylvant |
| Cumberland Pharmaceuticals, INC. | $16.05 | 2024 | Sancuso |
| Fennec Pharmaceuticals, INC. | $14.50 | 2025 | Fyarro |
Drugs and devices associated with these payments
Keytruda $791Jakafi $658Enhertu $619Reblozyl $515Lynparza $459Lenvima $386Epkinly $358Verzenio $358Opdivo $313Jaypirca $302Tagrisso $298Kisqali $279Calquence $270Xpovio $270Ayvakit $257Retevmo $245Cabometyx $235Besremi $234Adcetris $232Welireg $225Monjuvi $219Scemblix $218Orserdu $211Venclexta $198Pemazyre $190Libtayo $186Iclusig $186Onivyde $181Elahere $161Tivdak $160Opdualag $156Fruzaqla $155Elrexfio $154Trodelvy $150Erleada $145Xtandi $140Carvykti $140Gilotrif $138Tukysa $136Pluvicto $124Imfinzi $115Zejula $113Jemperli $113Pyrukynd $112Yonsa $107Odomzo $107Braftovi $105Fabhalta $105Vitrakvi $103Stivarga $103Ultomiris $98.24Lorbrena $96.55Lonsurf $95.99Inqovi $95.99Bosulif $91.99Mektovi $91.08Sarclisa $90.87Vonjo $88.63Ojjaara $86.34Imbruvica $85.60Ibrance $82.68Talvey $81.30Tecvayli $81.30Tabrecta $79.35Padcev $75.99Tazverik $72.54Rybrevant $71.78Qinlock $71.12Romvimza $71.12Bavencio $69.51Zoladex $67.60Tavalisse $67.46Nubeqa $64.69Wayrilz $63.79Keytruda Qlex $62.86Darzalex $59.66Mi Cancer Seek $53.99Inlyta $51.72Oxbryta $51.24Vectibix $51.20Xgeva $51.20Nplate $51.20Brukinsa $48.33Xalkori $47.63Alunbrig $47.59Besponsa $45.78Optune Lua (Novottf-200t) $42.52Polivy $39.46Pylarify $39.22Cosela $38.79Rezlidhia $36.31Jevtana $35.94Krazati $35.22Imkeldi $34.84Zynlonta $33.75Amtagvi $32.83Talzenna $32.60Kimmtrak $31.91Nerlynx $29.98Elzonris $29.92
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Polly Lin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.